Peptide Synthesis Market Analysis

Product (Equipment, Reagents & Consumables)

The reagent & consumable segment is expected to dominate the global market registering a CAGR of 53% by the end of 2037. This section includes both inorganic and organic substances that are employed in the production of various peptide types. The market is expanding as a result of the growing need for peptides in medication discovery and research. For instance, research on peptide hormones resulted in 6020 items in the HORDB database, comprising 5720 peptide hormones and 42 peptide medicines.

End User {Pharmaceutical & Biotechnology Companies, Contract Development & Manufacturing Organization (CDMO), Research Institutes}

The pharmaceutical and biotechnology company segment is estimated to witness the highest CAGR of 35% in the estimated period. The segment's expansion may be ascribed to the brisk expansion of biotechnology and pharmaceutical firms, the rise in biologic drug production, and expanding public knowledge of peptide synthesis technology. The Indian pharmaceutical sector is set to reach USD 130 billion by the end of 2030. Peptide synthesis technology is in higher demand due to the growth in the amount of pharma and biotechnology firms, which has resulted in the creation of more sophisticated peptide synthesis products.

Our in-depth analysis of the global market includes the following segments: